Filing Details
- Accession Number:
- 0001127602-13-003200
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-30 17:11:17
- Reporting Period:
- 2013-01-28
- Filing Date:
- 2013-01-30
- Accepted Time:
- 2013-01-30 17:11:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 912183 | Cubist Pharmaceuticals Inc | CBST | Pharmaceutical Preparations (2834) | 223192085 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1219016 | W Michael Bonney | 65 Hayden Avenue Lexington MA 02421 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-01-28 | 40,352 | $8.23 | 182,852 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-01-28 | 40,352 | $43.09 | 142,500 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-01-29 | 65,100 | $8.23 | 207,600 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-01-29 | 65,100 | $42.85 | 142,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2013-01-28 | 40,352 | $0.00 | 40,352 | $8.23 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2013-01-29 | 65,100 | $0.00 | 65,100 | $8.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 65,100 | 2003-05-26 | 2013-02-26 | No | 4 | M | Direct |
| 0 | 2003-05-26 | 2013-02-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 6,277 | Indirect | 401(k) Plan |
Footnotes
- Sold pursuant to a 10(b)5-1 Plan
- This transaction was executed in multiple trades at prices ranging from $42.74 to $43.43. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $42.66 to $43.098. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- Option vests 6.25% quarterly over a four-year period.
Billionaire Hedge Funds
